Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Plenary Session 6: The Cancer Epigenome

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Targeted inhibition of chromatin modifying enzymes as cancer therapeutics: The HDAC inhibitor vorinostat and beyond
Dr. Victoria M. Richon
EpiZyme, Inc., Cambridge, MA
from 2009 Molecular Targets and Cancer Therapeutics conference on November 18, 2009 10:30 AM-12:30 PM
Sensitivity and Resistance to DNA Hypomethylators
Dr. Jean-Pierre J. Issa
UT M.D. Anderson Cancer Center, Houston, TX
from 2009 Molecular Targets and Cancer Therapeutics conference on November 18, 2009 10:30 AM-12:30 PM
Cellular Reprogramming: Clues to Establishing, and Targeting, the Cancer Epigenome
Dr. Stephen B. Baylin
Johns Hopkins University School of Medicine, Baltimore, MD
from 2009 Molecular Targets and Cancer Therapeutics conference on November 18, 2009 10:30 AM-12:30 PM
Cracking chromatin open with DNA methylation inhibitors
Dr. Peter A. Jones
USC/Norris Comprehensive Cancer Center, Los Angeles, CA
from 2009 Molecular Targets and Cancer Therapeutics conference on November 18, 2009 10:30 AM-12:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4